Lonza

0QNO.L | LSE | 0 Followers
CHF 568.00 -0.35% -CHF 2.00
Follow
Overview Metrics Financials
Loading...

Fair Price

WNK 893.56
Overvalued by 7.0%
To display the fair price of a share, you need to be a member of Bulios Black.

Profile

Lonza Group AG is a Swiss global company headquartered in Basel. It specializes in providing a wide range of products and services in the biotechnology and pharmaceutical industries. The company offers a broad portfolio of products including active pharmaceutical ingredients, biological and chemical raw materials, diagnostic and therapeutic tools, as well as development and manufacturing services. Lonza is known for its expertise in the development and manufacturing of biotechnology products, including biopharmaceuticals, vaccines, cell therapies, and genetic engineering. The company has a global presence and is considered one of the leaders in the biotechnology and pharmaceutical industries. Shares of Lonza Group AG are publicly traded on the Swiss stock exchange.

Feed

There are no posts to show right now.
Don't have an account? Join us

Log in to Bulios

Continue with Google
Continue with Apple
Continue with Facebook
Or use email and password
Reset password
Already a member? Log in

Create Bulios profile

Continue with
Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools
Menu StockBot
Tracker
Upgrade